Stroke prevention in atrial fibrillation: comparison of recent international guidelines

Area of Science:

• Cardiology
• Neurology
• Pharmacology

Background:

• Stroke prevention is crucial for managing atrial fibrillation (AF).
• The ABC pathway emphasizes stroke risk assessment and anticoagulation.
• Existing guidelines offer varying recommendations for AF management.

Purpose of the Study:

• To compare stroke/bleeding risk assessment and oral anticoagulation (OAC) recommendations across four major AF guidelines.
• To highlight unique aspects of the 2017 APHRS, 2018 ACCP, 2019 ACC/AHA/HRS, and 2020 ESC AF guidelines.
• To inform optimal thromboprophylaxis strategies in AF patients.

Main Methods:

• Comparative review of four key atrial fibrillation guidelines.
• Analysis of stroke risk assessment tools, specifically the CHA2DS2-VASc score.
• Evaluation of OAC recommendations, including preferred agent types (NOACs).

Main Results:

• All four guidelines endorse the CHA2DS2-VASc score for stroke risk stratification.
• OAC is recommended for AF patients with CHA2DS2-VASc scores ≥2 (males) or ≥3 (females).
• Guidelines stress periodic stroke risk reassessment and management of modifiable bleeding risk factors.

Conclusions:

• Consistent use of CHA2DS2-VASc score across guidelines aids stroke risk assessment in AF.
• Oral anticoagulation, preferably NOACs, is recommended for moderate-to-high risk AF patients.
• Regular reassessment of stroke and bleeding risks is vital for guiding OAC decisions and optimizing patient care.